Manousos E. Kambouris
  • Post-Doc, University of Patras Rio, Patras
  • Microbiology, Molecular Biology, Biosecurity


PhD, National Kapodistrian University of Athens, 2000


George P Patrinos Lab of Pharmacogenomics and Individualized Therapy, Dept of Pharmacy, University of Patras


Molecular Diagnostics
Culturomics /Electroculturomics


1. Velegraki, et al. “Rapid extraction of fungal DNA from clinical samples for PCR amplification". Medical Mycol. 1999, 37, 69-73.
2. Velegraki et al. "Identification of medically significant fungal genera by Polymerase Chain Reaction followed by Restriction Enzyme Analysis". FEMS Immunol. Med. Microbiol. 1999, 23, 303-12.
3. Kambouris, et al. "Sequences from the aspergillopepsin PEP gene of Aspergillus fumigatus: Evidence on their use in selective PCR identification of Aspergillus species in infected clinical samples". FEMS Immunol. Med. Microbiol. 1999, 25, 255-64.
4. Kambouris, et al. Differential diagnosis of filamentous fungi by unitary digestion of PCR products. Arch Hell Med, 2000, 17 (2): 171-179. [Greek]
5. Kambouris, Velegraki A. “Aspergillus fumigatus, A. flavus και A. niger: Aerodynamic, immunological and metabolic virulence and determinants. Arch Hell Med, 2001, 18 (1): 20-34. [Greek]
6. A. Velegraki, M.E. Kambouris. Arrays and multiplex PCR: Revolutionary molecular biological methods with applications in biomedical practice. Arch Hell Med 2003, 20 (4): 425-45. [Greek]
7. Wang, et al. “A genotyping system capable of simultaneously analyzing 1.000 Single Nucleotide Polymorphisms in a haploid genome”, Genome Research 2005, 15 (2): 276-89.
8. Grivas et al “Mid-Term Deployability and geointegration concerns in biodefense sampling and detection hardware design and procedures” Defensor Pacis 2008, 22: 111-6.
9. Toukas D * , Kambouris ME*, et al. «Sequence basis of the serotyping and subtyping efficiency of URA-A/B PCR in Cryptococcus neoformans and indications for one-way multilocus allelic shift», e-Journal of Science & Technology (e-jst) 2011, 3(6): 1-12.
10. Kambouris ME “Staged oligonucleotide design, compilation and quality control procedures for multiple SNP genotyping by Multiplex PCR and Single Base Extension Microarray format”, e-Journal of Science & Technology (e-JST) 2009, 4 (4): 21-40.
11. Kambouris ME “Discrepancies in database-dependent research and proactive management of project procedures and structure to adapt”, e-Journal of Science & Technology (e-JST) 2010, 5 (3): 1-10.
12. Zachariou et al. Variable concentration of agarose gels and distinct applicability criteria. e-Journal of Science & Technology (e-jst) 2009, 4 (2): 13-24.
13. Hlia et al. «Retroactive buffering of agarose gels for alternate usage. 2009, Appl. Clin Microbiol & Lab Diagn 2009, 14 (4): 210-6 [Greek].
14. Kambouris et al “Methodology And Determining Criteria For Growth Phase Of Simultaneous Fungal Solid Cultures”. e-Journal of Science & Technology (e-jst) 2011, 4(6): 1-8. [In Greek]
15. Hini, et al. “Candidiasis In Hiv-Positive Patients In Greece: Conventional Epidemiological Data And Evaluation Of The Clinical Resistance Of Candida Species To Seven Antifungal Agents.” , e-Journal of Science & Technology (e-JST) 2010, 5 (4): 87-93.
16. Kambouris ΜΕ «Integrated Real-Time Pcr Formats: Methodological Analysis And Comparison Of Two Available Industry Options.» , e-Journal of Science & Technology (e-JST) 2010, 5 (5): 33-40.
17. Velegraki Α., Kambouris MΕ. The adaptive genome: A hypothesis and its possible impact on diagnostic methodology. Arch Hell Med, 2011, 28 (3): 317-22. [Greek]
18. Arabatzis, et al. “Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece.” Antimicrob Agents Chemother. 2011. 55 (6): 3025-30.
19. Kollia, et al. linical-oriented polyphasic identification, typing and susceptibility methodology for Candida rugosa isolates to establish potential virulence markers and processing guidelines. e-Journal of Science & Technology (e-JST) 2012, 1 (7): 43-54.
20. Toubouli, et al. “Corporate Social Responsibility in Greek pharmaceutical companies”. (e-JST). 2012, 5(7): 43-57. [Greek]
21. Kambouris, et al. “The Combination of Aerobiology, Morphology and Genetic Manipulation of Fungal Spores Constitutes the Ultimate Biosecurity Threat”. Journal of Life Sciences 2013, 7(2) 131-134.
22. Hiliopoulos, et al. The evolution of ancient Greek medicine as a trade and a science: Study of the sources. Arch Hell Med, 2013, 30(5) 619-626. [Greek]
23. Kyriazis, et al. Molecular techniques for the detection and characterization of microorganisms. Arch Hell Med, 2014, 31(1) 23-40. [Greek]
24. Zagoriti, et al. Recent Advances in Genetic Predisposition of Myasthenia Gravis. Biomedical Research International 2013, 1-12.
25. Kambouris, et al. From therapeutic Electrotherapy to Electroceuticals: Formats, Applications and Prospects of Electrostimulation. Annual Research and Review in Biology 2014, 4(20): 3054-3070.
26. Kambouris, et al. Reviewing the US Select Agents and Toxins List with More Efficient Assessment of the Potential Applicability of Microbes in Bioterrorism: The Fungal Agent. American Journal of Bioterrorism, Biosecurity and Biodefense 2014, 1(1)1- 3.
27. Kambouris, et al. Fungal cultures in compartmentalized petri dish: opting for 3 in 1. Appl. Clin Microbiol & Lab Diagn 2015, 20(1) 59-63 [Greek]
28. Gkantouna et al. Introducing dAUTObase: a first step towards the global scale geoepidemiology of autoimmune syndromes and diseases. Bioinformatics, 2015 15;31(4):581-6.
29. Lagoumintzis et al. Wireless Micro Current Stimulation technology improves firework burn healing: Clinical applications of WMCS technology. 4th International Conference on Wireless Mobile Communication and Healthcare (Mobihealth), 2014 Athens 3-5 Nov. 2014 Pages: 172 –175.
30. Kambouris, et al. Two-step molecular methodology (pcr-rflp) for differential detection and broad identification of agriculturally-important fungi applicable in decentralized units of agricultural development. e-Journal of Science & Technology (e-JST) 2015, 10(3):1-11.
31. Kambouris ME. Population Screening for Hemoglobinopathy Profiling: Is the Development of a Microarray Worthwhile? Hemoglobin 2016, 40(4):240-6.
32. Kambouris, et al. Towards Total Biothreat Preparedness: Expanded Surveillance, Joint Monitoring, Pooled Resources And The Genomic Option. IJISET 2016, 3(7) 384-9.
33. Vozikis et al. Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy. Public Health Genomics 2016 19(6) 352-363.
34. Kambouris, et al. Wireless Electrostimulation: a new approach in combating infection? Future Microbiology 2017 12:255-65
35. Kambouris, et al. Culturomics: A new kid on the block of phenomics and pharmacomicrobiomics for personalized medicine. OMICS-JIB 2018 22(2)108-18.
36. Kambouris et al. Rebooting Bioresilience: A Multi-OMICS Approach to Tackle Global Catastrophic Biological Risks (GCBRs) and Next Generation Biothreats" OMICS-JIB 2018 22(1): 35-51.
37. Kambouris, et al. “Towards decentralized agrigenomics surveillance? A PCR-RFLP approach for adaptable and rapid detection of user-defined fungal pathogens in potato crops”. OMICS-JIB 2018 22(4):264-73.
38. Kambouris et al. «Humanome versus Microbiome: Games of Dominance and Pan-biosurveillance in the Omics Universe. OMICS-JIB 2018 22(8):528-538.
39. Manoussopoulos et al. Effects of Three Strawberry Entomopathogenic Fungi on the Prefeeding Behavior of the Aphid Myzus persicae. J Insect Behav 2019 32(2) 99-108.
40. Stathoulias et al. "Toward High-Throughput Fungal Electroculturomics and New Omics Methodologies in 21st Century Microbiology and Ecology". OMICS-JIB 2020 24(8): 493-504.
41. Kambouris, et al. “Point-of-Need molecular processing of biosamples using portable instrumentation to reduce turnaround time” Biosafety and health 2020 2(3):177-182.
42. Goudoudaki et al. 2021. “Fast, Scalable and Practical: An Alkaline DNA Extraction Pipeline for Emergency Microbiomics Biosurveillance”. OMICS-JIB 25(8):484-494.
43. Kambouris et al. 2022. “Beyond the Microbiome: Germ-ganism? An Integrative Idea for Microbial Existence, Organization, Growth, Pathogenicity and Therapeutics”. OMICS-JIB 26(4):206-2017.
44. Goudoudaki et al. 2023. “Can Water-Only DNA Extraction Reduce the Logistical Footprint of Biosurveillance and Planetary Health Diagnostics? Towards a New Method”. OMICS-JIB 27(3):116-126.
45. Kambouris ME 2023. “Global Catastrophic Biological Risks in the Post-COVID-19 World: Time to Act is Now” OMICS-JIB 27(4):153-170.
46. Kambouris et al. 2023. «Historical microbiology: research of past bioevents by integrating scholarship (re)sources to paleomicrobiology assets”. Future Microbiology 18:681-693.
47. Goudoudaki et al. 2023. “Fast and Sustainable Thermo-osmotic DNA Extraction Protocol for Trans-spectrum Contingency and Field Use”. Bio-protocol 13(17): e4796.
48. Skiada et al. 2023. “Classification of olive cultivars by machine learning based on olive oil chemical composition” Food Chemistry 429: 136793
49. Kambouris et al 2023. "The biote-bot hybrid. The ultimate biothreat merging nanobots, AI-enabled cybernetics and synthetic biology." Future Medicine-AI 1(1): (
50. Spanou et al. 2023. “Introducing multifactorial electroculturomics: Alternating Current Electric Pulses, combined with mild thermal treatment, exhibit antimicrobial or stimulatory effects on bacterial pathogens and enteroviruses, implying prospects for targeted microbiomics applications”. BIORXIV 10.1101/2023.11.24.568545v1.full
51. Skokou et al 2024. “Clinical implementation of preemptive pharmacogenomics in psychiatry” EBioMedicine 101:105009.